BMJ Neurology Open (Jul 2020)

Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity

  • Elisaveta Sokolov,
  • Philipp Karschnia,
  • Reuben Benjamin,
  • Robert D M Hadden,
  • Robert C D Elwes,
  • Lee Drummond,
  • Devyani Amin,
  • Vitor Paiva,
  • Alex Pennisi,
  • Aline Herlopian,
  • Matthew Frigault,
  • Robin Sanderson,
  • Jorg Dietrich,
  • Shafqat Inam,
  • Andrew J Cole

DOI
https://doi.org/10.1136/bmjno-2020-000054
Journal volume & issue
Vol. 2, no. 1

Abstract

Read online

Aim We aimed to characterise language dysfunction and define electroencephalographic signatures after CAR-T cell therapy.Methods We reviewed the clinical presentation and EEG findings of 20 adult patients presenting with language dysfunction after CAR-T cell infusion. The cohort included a subset of patients treated with investigational CD19-directed CAR-T cells for non-Hodgkin’s lymphoma (n=17), acute lymphoblastic leukaemia (n=1), follicular lymphoma (n=1) and chronic lymphocytic leukaemia (n=1).Results Language dysfunction presented within 14 days of CAR-T cell infusion in 16 (84%) patients. Ten (50%) patients had mild word-finding difficulties and 10 (50%) had marked dysphasia with profound word-finding difficulties; the latter were all associated with generalised rhythmic delta activity or generalised periodic discharges on EEG.Conclusions Language dysfunction after CAR-T cell therapy is associated with generalised EEG abnormalities.